Marga  Ortigas-Wedekind net worth and biography

Marga Ortigas-Wedekind Biography and Net Worth

Director of HeartBeam

Marga Ortigas-Wedekind, Board member combines over 30 years of experience in health technology senior management. Ms. Ortigas-Wedekind has been Chief Commercial Officer of Fogarty Innovation, a non-profit educational incubator for early stage medtech companies since December 2019. From July 2015 through July 2019, Ms. Ortigas-Wedekind was the Executive Vice President of Marketing and Payer Relations for iRhythm Technologies Inc., a publicly-traded digital healthcare company. From 2009 to 2015, Ms. Ortigas-Wedekind was Executive Vice President, Global Marketing and Product Development of Omnicell Inc., a publicly-traded developer of automated medication dispensing and analytics systems where she led the Marketing, International and Engineering departments. From 2002 to December 2008, Ms. Ortigas-Wedekind was the Senior Vice President, Marketing, Development, and Clinical Affairs and Xoft, Inc, a developer of disruptive technology to deliver radiation therapy with capital equipment and high-end disposables. Ms. Ortigas-Wedekind is on the board of Itamar Medical (NASDAQ: ITMR), which provides digitally-enabled systems for sleep apnea management, Total Flow Cannula, an early stage company developing a mechanism to improve safety during on-pump open heart surgery and, the Bay Area Cancer Coalition, a non-profit organization that supports those affected by breast or ovarian cancer. Ms. Ortigas-Wedekind is a limited partner and advisory board member for Launchpad digital health, a venture fund focused on digital heath technologies and is also an angel investor with Health Tech Capital. Ms. Ortigas-Wedekind has an undergraduate degree from Wellesley College and an MBA from the Stanford Graduate School of Business.

What is Marga Ortigas-Wedekind's net worth?

The estimated net worth of Marga Ortigas-Wedekind is at least $50.51 thousand as of April 16th, 2026. Ms. Ortigas-Wedekind owns 137,293 shares of HeartBeam stock worth more than $50,510 as of September 30th. This net worth evaluation does not reflect any other investments that Ms. Ortigas-Wedekind may own. Learn More about Marga Ortigas-Wedekind's net worth.

How do I contact Marga Ortigas-Wedekind?

The corporate mailing address for Ms. Ortigas-Wedekind and other HeartBeam executives is 1000 CEDAR HOLLOW ROAD, MALVERN PA, 19355. HeartBeam can also be reached via phone at 610-729-7000 and via email at [email protected]. Learn More on Marga Ortigas-Wedekind's contact information.

Has Marga Ortigas-Wedekind been buying or selling shares of HeartBeam?

Marga Ortigas-Wedekind has not been actively trading shares of HeartBeam during the past quarter. Most recently, on Thursday, April 16th, Marga Ortigas-Wedekind bought 25,000 shares of HeartBeam stock. The stock was acquired at an average cost of $0.80 per share, with a total value of $20,000.00. Following the completion of the transaction, the director now directly owns 137,293 shares of the company's stock, valued at $109,834.40. Learn More on Marga Ortigas-Wedekind's trading history.

Who are HeartBeam's active insiders?

HeartBeam's insider roster includes Marga Ortigas-Wedekind (Director), and Branislav Vajdic (President, Director). Learn More on HeartBeam's active insiders.

Are insiders buying or selling shares of HeartBeam?

In the last year, HeartBeam insiders bought shares 7 times. They purchased a total of 1,118,750 shares worth more than $895,000.00. In the last year, insiders at the medical research company sold shares 3 times. They sold a total of 307,146 shares worth more than $1,077,090.03. The most recent insider tranaction occured on April, 16th when CFO Tim Cruickshank bought 31,250 shares worth more than $25,000.00. Insiders at HeartBeam own 18.0% of the company. Learn More about insider trades at HeartBeam.

Information on this page was last updated on 4/16/2026.

Marga Ortigas-Wedekind Insider Trading History at HeartBeam

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/16/2026Buy25,000$0.80$20,000.00137,293View SEC Filing Icon  
See Full Table

Marga Ortigas-Wedekind Buying and Selling Activity at HeartBeam

This chart shows Marga Ortigas-Wedekind's buying and selling at HeartBeam by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

HeartBeam Company Overview

HeartBeam logo
BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.
Read More

Today's Range

Now: $0.37
Low: $0.36
High: $0.38

50 Day Range

MA: $0.47
Low: $0.36
High: $0.59

2 Week Range

Now: $0.37
Low: $0.36
High: $4.00

Volume

4,039 shs

Average Volume

973,169 shs

Market Capitalization

$20.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A